TissueGnostics (TG) is a globally active Austrian company focusing on integrated solutions for high content and/or high throughput scanning and analysis of biomedical, veterinary, natural sciences and technical microscopy samples.
TG has been founded by scientists from the Vienna University Hospital (AKH) in 2003. It is now has subsidiaries in the EU, the USA and China and customers in 30 countries on all continents.
TG and Personalised Medicine
TG has been focusing on research for what was to become "Personalized Medicine" from the founding of the company - so it is only natural that the topic is now at the center of the company's activities.
In a definition used by the UKs NHS, "Personalised medicine is a move away from a ‘one size fits all’ approach to the treatment and care of patients with a particular condition, to one which uses new approaches to better manage patients’ health and targets therapies to achieve the best outcomes in the management of a patient’s disease or predisposition to disease."
TG scanning systems are currently based on versatile automated microscopy systems with or without image analysis capabilities. We strive to provide cutting-edge technology solutions, such as multispectral imaging and context-based image analysis as well as established features like Z-Stacking and Extended Focus. This is combined with a strong emphasis on automation, ease of use of all solutions and the production of publication-ready data.
TGs cutting-edge Contextual Tissue Cytometry analysis software, apart from being integrated into full systems is fully standalone capable and supports a wide variety of scanner image formats as well as digital images taken with any microscope.
TG continuously cooperates with research groups and other companies in the industry to provide novel tools and applications to its customers.
TG on News Medical
TG has a presence on the News Medical open-access medical and life science hub.
News Medical is curating a constantly-expanding index of free content including recent innovations in healthcare, research and technology and has over 53 million annual visitor sessions worldwide.